Physician profile
Mark J Fowler
NPI 1346220449
$1,789.48
in general payments reported to CMS, 2019-2025
25 companies · $14.08 in 2025
The $14.08 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $12.14 · 2021: $713 · 2022: $322 · 2023: $343 · 2024: $174 · 2025: $14.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $530.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $717.55 | 2019-2023 | |
| Exeltis, USA INC. | $162.56 | 2021-2024 | Slynd |
| Medtronic, INC. | $124.55 | 2021-2024 | Interstim, Ligasure |
| Hologic Sales and Service, LLC | $115.85 | 2019-2024 | Myosure Tissue Removal Device, Novasure |
| Bayer Healthcare Pharmaceuticals INC. | $102.72 | 2019-2024 | |
| Ethicon US, LLC | $82.00 | 2023 | Stratafix, Echelon; Endopath |
| Organon LLC | $79.18 | 2021-2024 | Nexplanon |
| Myovant Sciences INC. | $49.34 | 2021-2022 | |
| Evofem Biosciences, INC. | $47.01 | 2021-2022 | |
| Amgen INC. | $36.22 | 2019-2024 | Prolia, Evenity |
| Mayne Pharma Commercial LLC | $36.12 | 2022 | |
| Avion Pharmaceuticals | $27.17 | 2021-2022 | |
| Astellas Pharma US INC | $24.35 | 2024 | Veozah |
| Boston Scientific Corporation | $23.54 | 2019 | |
| Medtronic USA, INC. | $19.13 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $16.82 | 2019 | |
| Merck Sharp & Dohme LLC | $16.45 | 2019 | |
| Therapeuticsmd, INC. | $15.81 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.76 | 2021 | |
| Meditrina | $15.76 | 2022 | |
| Minerva Surgical, INC | $15.35 | 2023 | |
| Pfizer INC. | $14.08 | 2025 | |
| Allergan, INC. | $12.14 | 2020 | |
| Duchesnay USA Incorporated | $10.98 | 2019 | |
| Intuitive Surgical, INC. | $9.04 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Fowler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.